National Analysis of Outcomes for Adult Trauma Patients With Isolated Severe Blunt Traumatic Brain Injury Following Venous Thromboembolism Prophylaxis
- PMID: 38815515
- DOI: 10.1016/j.jss.2024.04.075
National Analysis of Outcomes for Adult Trauma Patients With Isolated Severe Blunt Traumatic Brain Injury Following Venous Thromboembolism Prophylaxis
Abstract
Introduction: We aim to evaluate the association of early versus late venous thromboembolism (VTE) prophylaxis on in-hospital mortality among patients with severe blunt isolated traumatic brain injuries.
Methods: Data from the American College of Surgeons Trauma Quality Program Participant Use File for 2017-2021 were analyzed. The target population included adult trauma patients with severe isolated traumatic brain injury (TBI). VTE prophylaxis types (low molecular weight heparin and unfractionated heparin) and their administration timing were analyzed in relation to in-hospital complications and mortality.
Results: The study comprised 3609 patients, predominantly Caucasian males, with an average age of 48.5 y. Early VTE prophylaxis recipients were younger (P < 0.01) and more likely to receive unfractionated heparin (P < 0.01). VTE prophylaxis later than 24 h was associated with a higher average injury severity score and longer intensive care unit stays (P < 0.01). Logistic regression revealed that VTE prophylaxis later than 24 h was associated with significant reduction of in-hospital mortality by 38% (odds ratio 0.62, 95% confidence interval 0.40-0.94, P = 0.02). Additionally, low molecular weight heparin use was associated with decreased mortality odds by 30% (odds ratio 0.70, 95% confidence interval 0.55-0.89, P < 0.01).
Conclusions: VTE prophylaxis later than 24 h is associated with a reduced risk of in-hospital mortality in patients with severe isolated blunt TBI, as opposed to VTE prophylaxis within 24 h. These findings suggest the need for timely and appropriate VTE prophylaxis in TBI care, highlighting the critical need for a comprehensive assessment and further research concerning the safety and effectiveness of VTE prophylaxis in these patient populations.
Keywords: Early venous thromboprophylaxis; Patient safety; Trauma outcomes; Traumatic brain injuries.
Copyright © 2024 Elsevier Inc. All rights reserved.
Similar articles
-
Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.J Trauma Acute Care Surg. 2017 Jul;83(1):151-158. doi: 10.1097/TA.0000000000001494. J Trauma Acute Care Surg. 2017. PMID: 28426561 Free PMC article.
-
Low-molecular-weight heparin versus unfractionated heparin in pediatric traumatic brain injury.J Neurosurg Pediatr. 2021 Feb 12;27(4):469-474. doi: 10.3171/2020.9.PEDS20615. J Neurosurg Pediatr. 2021. PMID: 33578391
-
Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.J Trauma Acute Care Surg. 2012 Sep;73(3):625-8. doi: 10.1097/TA.0b013e318265cab9. J Trauma Acute Care Surg. 2012. PMID: 22929493
-
Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine.Ann Intensive Care. 2023 May 11;13(1):41. doi: 10.1186/s13613-023-01135-8. Ann Intensive Care. 2023. PMID: 37165105 Free PMC article. Review.
-
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.Cochrane Database Syst Rev. 2014 Aug 29;(8):CD008500. doi: 10.1002/14651858.CD008500.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2016 Dec 01;12:CD008500. doi: 10.1002/14651858.CD008500.pub4. PMID: 25171736 Updated. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
